These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25773924)

  • 1. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
    Kim HR; Lee HN; Lim K; Surh YJ; Na HK
    Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15-Deoxy-Δ
    Jang HO; Lee HN; Woo JH; Lee JY; Kim A; Lee JK; Kim DH; Surh YJ; Na HK
    Free Radic Res; 2019 Mar; 53(3):335-347. PubMed ID: 30717608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells.
    Kim EH; Na HK; Surh YJ
    Ann N Y Acad Sci; 2006 Dec; 1090():375-84. PubMed ID: 17384282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Deoxy-Δ
    Park JM; Na HK
    J Cancer Prev; 2019 Sep; 24(3):183-191. PubMed ID: 31624724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS.
    Kim DH; Kim JH; Kim EH; Na HK; Cha YN; Chung JH; Surh YJ
    Carcinogenesis; 2009 Apr; 30(4):645-54. PubMed ID: 19136476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxy-Δ12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species.
    Kitz K; Windischhofer W; Leis HJ; Huber E; Kollroser M; Malle E
    Free Radic Biol Med; 2011 Apr; 50(7):854-65. PubMed ID: 21236332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Deoxy-Delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS.
    Kim EH; Na HK; Kim DH; Park SA; Kim HN; Song NY; Surh YJ
    Carcinogenesis; 2008 Apr; 29(4):688-95. PubMed ID: 18192694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone.
    Greenland KJ; Jantke I; Jenatschke S; Bracken KE; Vinson C; Gellersen B
    Endocrinology; 2000 Feb; 141(2):581-97. PubMed ID: 10650939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
    Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
    Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-Δ12,14-prostaglandin J₂ induces p53 expression through Nrf2-mediated upregulation of heme oxygenase-1 in human breast cancer cells.
    Kim DH; Song NY; Kim EH; Na HK; Joe Y; Chung HT; Surh YJ
    Free Radic Res; 2014 Sep; 48(9):1018-27. PubMed ID: 24568186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
    Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-Δ
    Suh J; Kim DH; Kim EH; Park SA; Park JM; Jang JH; Kim SJ; Na HK; Kim ND; Kim NJ; Suh YG; Surh YJ
    Cancer Lett; 2018 Jun; 424():30-45. PubMed ID: 29550515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
    Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
    Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets.
    Corwin C; Nikolopoulou A; Pan AL; Nunez-Santos M; Vallabhajosula S; Serrano P; Babich J; Figueiredo-Pereira ME
    J Neuroinflammation; 2018 Sep; 15(1):272. PubMed ID: 30236122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.